If the plateau sticks around, it might be time to shake things up
However, postmarketing reports and patient cohort studies suggest occasional UTI clustering in GLP-1 users, likely attributable to secondary factors rather than direct pharmacological action
Repeat bloodwork 4-8 weeks after completing a BPC-157 cycle
The switch depends on your remaining beta cell function, current glucose control, overall health status, and treatment goals
In vitro , SGLT2 exhibited antitumor activity by augmenting caspase 3 cleavage activity and modulating the expression of Bax/Bcl-2 (Xie et al., 2020)
The current once-weekly subcutaneous injection model works, but once-monthly or even implantable formulations are on the horizon